We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

174 hedge funds and large institutions have $802M invested in AMAG Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 74 increasing their positions, 58 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 58

6% less funds holding

Funds holding: 185 → 174 (-11)

12% less capital invested

Capital invested by funds: $913M → $802M (-$111M)

38% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 26

70% less call options, than puts

Call options by funds: $4.04M | Put options by funds: $13.4M

Holders
174
Holders Change
-11
Holders Change %
-5.95%
% of All Funds
4.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
74
Reduced
58
Closed
26
Calls
$4.04M
Puts
$13.4M
Net Calls
-$9.37M
Net Calls Change
+$158M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$33.7M
2
Invesco
Invesco
Georgia
+$26.6M
3
Millennium Management
Millennium Management
New York
+$22.8M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.7M
5
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$6.63M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$12.6M
2
AL
AJO LP
Pennsylvania
-$10.6M
3
NI
Numeric Investors
Massachusetts
-$8.09M
4
Deutsche Bank
Deutsche Bank
Germany
-$7.93M
5
JP Morgan Chase
JP Morgan Chase
New York
-$6.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$8.55M +$530K +26,725 +6%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$6.68M +$16.4K +830 +0.2%
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$6.63M +$3.43M +172,851 +92%
AQR Capital Management
29
AQR Capital Management
Connecticut
$5.77M +$2.58M +130,164 +71%
Charles Schwab
30
Charles Schwab
California
$5.35M -$237K -11,973 -4%
PPA
31
Parametric Portfolio Associates
Washington
$5.25M +$802K +40,490 +17%
Principal Financial Group
32
Principal Financial Group
Iowa
$4.92M +$112K +5,632 +2%
American Century Companies
33
American Century Companies
Missouri
$3.85M +$125K +6,305 +3%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$3.81M -$236K -11,898 -5%
Ameriprise
35
Ameriprise
Minnesota
$3.41M +$30.1K +1,521 +0.8%
PAM
36
Panagora Asset Management
Massachusetts
$3.27M +$542K +27,335 +18%
TCIM
37
TIAA CREF Investment Management
New York
$3.18M +$975K +49,209 +40%
Skandinaviska Enskilda Banken (SEB)
38
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.05M +$141K +7,100 +4%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$3.05M +$212K +10,700 +7%
AC
40
Ascend Capital
California
$3.04M +$3.28M +165,476 New
GC
41
Guggenheim Capital
Illinois
$3.03M +$516K +26,042 +19%
CEI
42
Clark Estates Inc
New York
$2.76M +$594K +30,000 +25%
BCM
43
Breithorn Capital Management
New York
$2.64M +$2.85M +143,700 New
OAM
44
Oxford Asset Management
United Kingdom
$2.63M -$1.12M -56,761 -28%
Citigroup
45
Citigroup
New York
$2.59M +$882K +44,504 +46%
Deutsche Bank
46
Deutsche Bank
Germany
$2.51M -$7.93M -400,413 -75%
Allianz Asset Management
47
Allianz Asset Management
Germany
$2.39M -$109K -5,525 -4%
UONDDL
48
University of Notre Dame du Lac
Indiana
$2.27M +$367K +18,538 +18%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$2.13M +$982K +49,560 +75%
QI
50
QS Investors
New York
$1.78M -$242K -12,200 -11%
1
2
3 4 5

AMAG Hedge Fund Activity: Q2 2017 in Review

174 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q2 2017, worth a combined $802M — down 12% from $913M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AMAG and 16 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 74 added.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $33.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $12.6M sold.

  • 174 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q2 2017, down from 185 in Q1 2017.
  • Funds reported $802M of AMAG Pharmaceuticals stock for Q2 2017, down 12% quarter-over-quarter.
  • 16 funds opened new AMAG Pharmaceuticals positions in Q2 2017 and 26 closed out, a net change of -10 holders.
  • The largest AMAG Pharmaceuticals buyer in Q2 2017 was Camber Capital Management, an estimated $33.7M added.
  • The largest AMAG Pharmaceuticals seller in Q2 2017 was Perceptive Advisors, an estimated $12.6M sold.

Based on aggregated 13F filings for Q2 2017.